Trials / Conditions / Hyperphagia in Prader-Willi Syndrome
Hyperphagia in Prader-Willi Syndrome
4 registered clinical trials studyying Hyperphagia in Prader-Willi Syndrome — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial NCT07197034 | Aardvark Therapeutics, Inc. | Phase 3 |
| Enrolling By Invitation | OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome NCT06420297 | ACADIA Pharmaceuticals Inc. | Phase 3 |
| Active Not Recruiting | Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome NCT06173531 | ACADIA Pharmaceuticals Inc. | Phase 3 |
| Completed | Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome NCT01968187 | Ferring Pharmaceuticals | Phase 2 |